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AbstrACt 
Introduction Asthma is a leading cause of youth 
morbidity in the USA, affecting >8% of youth. Adherence 
to inhaled corticosteroids (ICS) can prevent asthma-
related morbidity; however, the typical adolescent with 
asthma takes fewer than 50% of their prescribed doses. 
Adolescents are uniquely vulnerable to suboptimal asthma 
self-management due to still-developing executive 
functioning capabilities that may impede consistent self-
regulation and weaken attempts to use problem solving to 
overcome barriers to ICS adherence.
Methods and analysis The aims of this project are to 
improve adherence to ICS as an important step towards 
better self-management among adolescents aged 13–17 
years diagnosed with asthma by merging the efficacious 
behaviour change strategies found in behavioural health 
interventions with scalable, adaptive mobile health 
(mHealth) technologies to create the Responsive Asthma 
Care for Teens programme (ReACT). ReACT intervention 
content will be developed through an iterative user-centred 
design process that includes conducting (1) one-on-one 
interviews with 20 teens with asthma; (2) crowdsourced 
feedback from a nationally representative panel of 100 
adolescents with asthma and (3) an advisory board of 
youth with asthma, a paediatric pulmonologist and a 
behavioural health expert. In tandem, we will work with 
an existing technology vendor to programme ReACT 
algorithms to allow for tailored intervention delivery. 
We will conduct usability testing of an alpha version 
of ReACT with a sample of 20 target users to assess 
acceptability and usability of our mHealth intervention. 
Participants will complete a 4-week run-in period to 
monitor their adherence with all ReACT features turned 
off. Subsequently, participants will complete a 4-week 
intervention period with all ReACT features activated. 
The study started in October 2018 and is scheduled to 
conclude in late 2019.
Ethics and dissemination Institutional review board 
approval was obtained at the University of Kansas and 
the University of Florida. We will submit study findings 
for presentation at national research conferences that 
are well attended by a mix of psychologists, allied health 
professionals and physicians. We will publish study 
findings in peer-reviewed journals read by members of the 
psychology, nursing and pulmonary communities.
IntroduCtIon
Asthma affects over 8% of youth and is a 
leading cause of morbidity.1 2 Some asthma 
symptoms and healthcare utilisation could 
be prevented via consistent engagement in 
disease self-management behaviours (eg, 
symptom recognition and monitoring, appro-
priate administration of medications).2 3 
Adherence to daily controller medications, 
such as inhaled corticosteroids (ICS), is 
central to control asthma and reduce 
morbidity for youth with persistent asthma.2 
ICS adherence rates with adolescents are 
often <50%,4 5 placing them at significant 
risk for reduced lung function, increased 
morbidity and poor quality of life.4 6 We 
posit that the complexity of the asthma treat-
ment regimen coupled with still-developing 
executive functioning and problem-solving 
strengths and limitations of this study
 ► Intervention content will be developed first with 
theory and evidence-based decision-making and 
refined via an iterative, user-centred approach with 
target users and key stakeholders.
 ► Adaptive algorithms will be programmed into an ex-
isting, patient-facing asthma management platform.
 ► Intervention usability and acceptability will be strin-
gently assessed prior to efficacy testing to allow for 
modifications and improvements.
 ► Although we will have data on patient preferences, 
usability and acceptability, the current protocol is not 
designed to evaluate the efficacy of the Responsive 
Asthma Care for Teens (ReACT) programme; this 
limitation will be addressed in a future randomised 
controlled trial.
 ► While medical providers were involved in the de-
velopment of interviews, content and interpretation 
of results, the current protocol will not incorporate 
shared decision-making between patients and pro-
viders in the intervention given the focus of ReACT.
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abilities makes adolescents uniquely vulnerable to subop-
timal asthma self-management through self-regulation 
deficits.7–11 
The importance of self-regulation in asthma self-man-
agement is well-supported.12–17 Because the self-regu-
lation abilities that are needed to successfully manage 
one’s own asthma are linked to brain regions that are 
still developing in adolescents (ie, frontal lobes respon-
sible for top-down control), external supports in the 
form of parents or technology may be required to ensure 
that dosing occurs as prescribed. Simply put, to develop 
self-regulation, adolescents with chronic and persistent 
asthma need to spend time thinking about their asthma, 
medication and actively planning how to incorporate 
adherence into their lives. Developmentally, adolescents’ 
executive functioning skills may not be ideally suited for 
this task as evidenced by data indicating that adolescents 
take their medication as prescribed on some occasions, 
and nearly every adolescent misses some doses on some 
occasions.18 19
Similar to the problem of underdeveloped self-regu-
latory skill, it is common for adolescents with persistent 
asthma to be met with barriers to ICS adherence that 
they may not have the experience or cognitive develop-
ment to effectively problem-solve.12 20 Indeed, intraper-
sonal factors such as attitudes (eg, motivation), feelings 
(eg, mood, stress) and external factors such as the social 
and family environment, have consistently been associ-
ated with asthma management behaviours and disease 
outcomes.13 21–26 Efficacious behavioural interventions 
often attempt to actively reframe ICS adherence as central 
to an adolescent’s self-concept (eg, better lung function 
will allow you to pursue your interests). Once adolescents 
see adherence as helping them reach their own personal 
goals rather than as a chore, they are sufficiently moti-
vated to learn skills that can help ensure adherence to 
ICS. To this end, adolescents are taught to identify intra-
personal and external barriers to adherence and prob-
lem-solve around those barriers. Beyond simply teaching 
a formula for problem solving, many effective adherence 
promotion programmes tailor intervention content to 
personally salient barriers and help the adolescent iden-
tify and implement strategies specifically designed to 
increase the chances of regimen success.27–29
A persistent problem in this approach is the difficulty 
of relying on infrequent face-to-face visits (eg, for clin-
ical care) to implement interventions. Smartphones are 
habitually carried by >70% of adolescents30; as such, 
mobile technology provides a readily available medium 
to approximate the features of efficacious behavioural 
health interventions31 32 by leveraging passive monitoring, 
data listening, preprogrammed algorithms and content 
libraries focused on improving self-regulation and prob-
lem-solving skills.33 34 Despite their potential, existing 
mobile health (mHealth) interventions have been largely 
developed without the benefit of behavioural theory, 
use reminder-based approaches to behaviour change 
and lack the kinds of tailored problem-solving training 
that characterises efficacious in-person interventions35–37 
(for a systematic evaluation of behaviour change tech-
niques in current asthma self-management applications, 
see Ramsey et al37). We believe that this, at least in part, 
helps explain why very few existing mHealth interventions 
for asthma medication adherence have yet to demon-
strate their efficacy beyond active controls.38–40
There is a clear need for an mHealth intervention that 
merges digital delivery modalities with the theory-based 
behavioural framework and tailoring found in efficacious 
in-person treatments. Recent technological advances 
have catalysed the development of mobile-based interven-
tion platforms that deliver tailored support to individuals 
in a timely fashion.41 42 We propose to extend this work to 
paediatric asthma by developing Responsive Asthma Care 
for Teens (ReACT), an innovative adaptive mHealth inter-
vention that facilitates self-regulation by aiding adoles-
cents in self-monitoring, goal setting and problem solving 
when adolescents’ adherence data indicate they need 
additional support the most (figure 1). We will outline 
how ReACT content will be developed, refined and tested 
through an iterative user-centred design process guided 
by theory and prior evidence.
MEthods And AnAlysIs
objectives
The aims of the study are: (1) conduct a hybrid user-cen-
tred and evidence-based design process comprising indi-
vidual interviews, crowdsourcing and advisory boards to 
develop ReACT content and features; (2) test the accept-
ability and usability of ReACT in a sample of 20 adoles-
cents with persistent asthma. We hypothesise that ReACT 
will be an acceptable and usable mHealth adherence 
promotion intervention as determined by high accept-
ability and usability ratings and themes from think aloud 
testing and qualitative one-on-one interviews with target 
users.
Project overview
This multisite study will take place at the University of 
Florida, University of Kansas and their affiliated clinics. 
The study commenced in October 2018 and is anticipated 
to be completed in late 2019. Features and intervention 
content of ReACT will be developed concurrently. We will 
work with a technology vendor to add functionality for 
ReACT to an existing mHealth adherence monitoring 
platform. We will use a strong theoretical framework and 
prior evidence combined with a series of user-centred 
design phases to determine what intervention content 
should populate the ReACT system (design phase I). 
Study team members and an advisory board will then 
refine intervention content and complete preliminary 
usability testing of ReACT (design phase II). Finally, 
we will conduct acceptability and usability testing using 
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Core reACt functionality
We will create ReACT by expanding the capabilities of an 
existing Android and iOS compatible mobile phone app 
that uses an integrated mobile sensor designed to fit onto 
an asthma metered dose inhaler or Diskus. The sensor 
works passively to sense when ICS or short-acting beta-ag-
onist medications are dispensed. Bluetooth is used to pass 
the information to the app, which has a set of optional 
features (eg, provide feedback about adherence) that can 
be turned on as intervention parameters dictate. Figure 3 
outlines an adolescent’s intervention experience through 
ReACT. Building from theory and prior evidence, core 
ReACT components in sequence are: (1) core education 
on asthma management and skills training content on goal 
setting and problem solving,4 43 (2) conditional activation 
of ReACT features when an adolescent is <80% adherent 
to their ICS, (3) an evidence-based goal-setting algorithm 
that shapes adherence to dosing recommendations over 
time, (4) timely assessment of an adolescent’s barriers to 
adherence and (5) delivery of tailored problem-solving 
training based on recent and salient barriers. Determi-
nants of self-regulation will be integrated into the core 
ReACT functionality to best scaffold support for adoles-
cents, as outlined below.
ReACT will begin with an orientation module within 
the app that guides the users through the platform, 
core educational and skills training modules and passive 
monitoring of medications. Adolescents will complete an 
asthma education module based on the National Heart, 
Lung and Blood Institute guidelines44 to ensure that they 
have an understanding of the importance of medication 
adherence as a means to avoid asthma-related impair-
ments. Adolescents will receive skills training on empir-
ically supported techniques consistent with our guiding 
self-regulation theory. Goal-setting content will use a 
Specific, Measurable, Attainable, Relevant, Time-Bound 
goal framework. Problem-solving skills training will focus 
on orienting to the problem, defining and formulating 
the problem, generating alternative solutions, deciding 
on a course of action and implementing a solution.45 46 
We will use engaging videos created by the team to deliver 
content. Participants will complete the orientation 
modules with study staff to encourage engagement and 
provide assistance if necessary.
Figure 1 ReACT conceptual model. Black arrows represent mechanistic processes occurring during the ReACT 
intervention period. Blue arrows indicate recursive processes happening repeatedly during the intervention period. ICS 
adherence, adherence to inhaled corticosteroids; ReACT, Responsive Asthma Care for Teens.  
Figure 2 Study timeline.
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ReACT will use passive sensing to objectively monitor 
rates of adolescent ICS adherence throughout the inter-
vention period. The use of the ICS adherence sensor 
offloads the burden of self-monitoring such that adoles-
cents do not have to remember or calculate their adher-
ence. Active intervention elements in ReACT will activate 
only when an adolescent falls below a clinically derived 
80% adherence threshold47 based on a 7-day rolling 
average, thus reducing intervention fatigue.42 If an 
adolescent has <80% adherence to ICS based on the 7-day 
rolling average, ReACT will prompt the adolescent to set 
a goal for adherence in the next 7-day period, a strategy 
with demonstrated efficacy in previous asthma adherence 
interventions.48 The algorithm will only allow goals that 
are reasonable given performance over the past week 
to avoid overly ambitious and unattainable goals. Each 
evening, the adolescent will receive a feedback message 
about how much their adherence that day moved them 
towards their goal, additionally facilitating the self-reg-
ulatory process of observation. Furthermore, the condi-
tional activation of the ReACT features should support 
self-regulatory skills, specifically judgement, by notifying 
the adolescent when his or her adherence declines.
ReACT will identify contextual barriers to ICS adher-
ence by also initiating an assessment as soon as the 7-day 
rolling average indicates that adherence is <80%. Specif-
ically, adolescents will be prompted via a push notifica-
tion to complete a brief electronic momentary assessment 
(EMA) survey of barriers identified from our pilot data 
and design phase I to identify what barrier the prob-
lem-solving content should be tailored to address. Partic-
ipants will answer brief questions in the app regarding 
barriers that got in the way of taking their ICS followed by 
a rank order item denoting which one to make the focus of 
their problem-solving efforts. Once a barrier is identified, 
ReACT will deliver problem-solving content in the app 
that is tailored to that specific barrier. For instance, if an 
adolescent has identified and chooses to work on stress as 
their top barrier to ICS adherence, the tailored problem 
solving will deliver structured problem-solving training 
using a flexible system of branching that is tailored to 
stress specifically. To execute this feature, ReACT will 
have several content banks that use the same structure. To 
illustrate the user experience, a possible problem-solving 
intervention could include: (1) defining the problem: 
participants will be presented with a standard message 
reflecting the problem they identified in the EMA survey; 
(2) setting a realistic, achievable goal: several goals will 
be presented and the participant will choose one and 
receive feedback on their choice; (3) generating multiple 
solutions: the participant will be asked to choose from a 
list of possible solutions for the goal that they selected 
in step #2; (4) evaluating pros and cons: participants will 
evaluate the pros and cons of multiple solutions listed in 
step #3; (5) selecting a solution: participants will choose 
the solution that may work the best; (6) making an action 
plan: participants will select from a list of action plans 
that correspond to the solution they have selected; (7) 
evaluating the outcome: after a week participants will be 
asked whether they implemented the solution selected 
in step #6. The goal-setting and tailored problem-solving 
process should enhance one’s reaction to suboptimal 
adherence by improving self-efficacy and facilitating skills 
to overcome their personalised adherence barriers.
Once an adolescent receives intervention content, ReACT 
will prompt adolescents to complete a survey in the app 2 days 
later to assess content use. If the participant responds that 
they used the intervention strategy, ReACT will assess the 
participant’s confidence in their ability to repeat the plan in 
the future. If the participant has not used the strategy, they 
will receive a supportive prompt with options to review the 
content they saw last time, see the same content in a different 
Figure 3 React participant flow. Diamonds indicate intervention decision rules. EMA, electronic momentary assessment; ICS, 
inhaled corticosteroids; ReACT, Responsive Asthma Care for Teens; SABA, short-acting beta-agonist.
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media format, review a different set of content on the same 
topic or set a goal to use the strategies by a specific time in the 
next 2 days. Another programme safeguard is to reduce over-
whelming participants with content; therefore, the tailored 
problem-solving process (figure 3) will only run once in a 
given 7-day window. This mirrors normative approaches for 
in-person interventions during which only one or two new 
concepts would be introduced each week.
Participants and recruitment
Participants
Participants will include four separate samples of adolescents 
aged 13–17 years with asthma and their caregivers (figure 4). 
Twenty adolescent-caregiver dyads will complete individual 
interviews, 100 adolescents will provide crowdsourced feed-
back via a national online panel, 4 adolescent-caregiver dyads 
will participate in advisory board meetings and 20 adoles-
cent-caregiver dyads will complete user testing of ReACT. 
We intend that at least half of adolescent participants in the 
interviews and advisory boards will be from racial and ethnic 
minority groups.
Inclusion and exclusion criteria
For interviews, advisory boards and user testing, adoles-
cents must have a physician-verified diagnosis of current 
asthma with persistent symptoms requiring regular ICS 
use for ≥6 months. They must have a daily ICS or ICS/
LABA prescription that is sensor-compatible, and they 
and their caregivers must speak and read English. Asthma 
status and prescription information will be verified via 
the electronic medical record. Families will be excluded 
from the study if the adolescent is currently involved in 
an asthma management intervention, has a comorbid 
chronic health condition that may impact lung function 
or has a significant cognitive impairment or develop-
mental delay that interferes with study completion. For 
crowdsourced feedback, inclusion will be determined 
at the level of a national online panel, which will screen 
participants for persistent asthma.
Recruitment
Participants will be recruited (1) through university-affil-
iated clinics and (2) via flyers. Research and clinic staff 
members with access to the electronic medical record will 
identify eligible patients with upcoming medical appoint-
ments. During these appointments, providers with clin-
ical relationships with the eligible participants will first 
approach the patients to determine their interest in 
hearing more about the study. Then, in coordination with 
the clinic staff, research staff will meet with interested 
patients to provide a study overview, complete in-person 
screening for eligibility and invite participation. In 
the event that a family is unable to complete screening 
Figure 4 ReACT flow of formative work. EMA, electronic momentary assessment; ICS, inhaled corticosteroids; ReACT, 
Responsive Asthma Care for Teens. 
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during a clinic visit, research staff will request permission 
for a member of the study team to contact patients for 
screening using an institutional review board (IRB)-ap-
proved ‘consent-to-contact’ form. A member of the study 
staff will then call interested participants to provide a study 
overview and invite participation. In addition, IRB-ap-
proved flyers will be posted or made available in clinics, 
community organisations, schools, physician offices and 
common areas. Flyers will encourage families and nurses 
to call our research office to learn about the project, 
determine initial eligibility and if eligible, schedule an 
in-person screening visit where informed consent will 
be collected prior to study enrolment. Throughout all 
phases of the project, participants will be incentivised and 
compensated for their participation.
reACt development
Patient and public involvement
Adolescents diagnosed with asthma, their caregivers and 
paediatric asthma providers are involved in all stages of 
ReACT development, as described below.
Design phase I: content development
We have developed a list of common barriers to ICS 
adherence from our own pilot data and the extant paedi-
atric asthma literature. Our goal for design phase I is 
to use individual interviews with adolescents diagnosed 
with asthma to translate these barriers into terms easily 
understood by adolescents, develop a final list of barriers 
to adherence and subsequently develop a library of inter-
vention content to overcome adherence barriers that is 
informed by self-regulation theory. Individual interview 
participants and their caregivers will also complete asth-
ma-related measures for sample description purposes and 
to obtain preliminary data on constructs of interest to the 
project (table 1). Adolescent-caregiver dyads will receive 
US$60 for their participation.
The study team will create an individual interview guide 
that will be used to identify what barriers to adherence 
are most salient to adolescents with asthma, and to solicit 
their opinion about the types of intervention content that 
they would prefer to receive when experiencing these 
barriers. Prior to the start of individual interviews, at least 
three paediatric asthma providers (eg, pulmonologists, 
nurses) will provide feedback on the interview guide. All 
interviews will be audio-recorded and conducted with 
self-regulation theory in mind. If a component of self-reg-
ulation theory is not discussed, we will probe for content 
in the omitted domain to facilitate development of inter-
vention content. Interviews will be transcribed and eval-
uated by the study team to inform digital intervention 
content development (see ‘Data analysis plan’ section).
Research staff with experience developing digital 
intervention content will leverage information gathered 
during design phase I to develop a library of intervention 
content for each barrier identified in the interviews and 
quantitative analysis of our pilot data. We anticipate that 
intervention content will include a combination of skills 
training videos, brief text content, educational videos 
and images. Delivery modality (SMS, app, etc) will be 
discussed with the advisory board.
Design phase II: refinement of content and preliminary usability 
testing
In design phase 2, we will refine intervention content 
generated in design phase I through (1) nationally crowd-
sourced feedback from adolescents with asthma and (2) 
advisory board meetings. Preliminary usability testing and 
iterative refinement will be conducted with our advisory 
board meetings (described below).
Nationally crowdsourced feedback will be solicited 
via an online panel and survey-technology provider. 
Participants will be identified from panels of adoles-
cents who have agreed to participate in research. These 
panels are accessed by our survey vendor through their 
business-to-business partnerships. Participants will be 
screened for persistent asthma using the following stan-
dard set of questions commonly used in epidemiological 
trials (eg, National Health Interview Survey): (1) Have 
you ever been told by a doctor, nurse or other health-
care professional that you have asthma? (2) Do you still 
have asthma? Affirmative answers to both questions will 
qualify an adolescent for participating.49 Participants 
will review intervention content and rate its appropriate-
ness using a dichotomous ‘yes’ (I like the message as it 
is) or ‘no’ (change it to make it better) response choice. 
They will receive US$15 for their participation. Content 
receiving ≥60% ‘no’ votes will be discarded, and those 
with ≤39% ‘no’ votes will be accepted as final interven-
tion content. Content with 40%–59% ‘no’ votes will be 
revised or clarified while retaining any theoretically or 
empirically derived concepts.50 We will design surveys 
to take no more than 30 min each. If necessary, we will 
split the content into two surveys to keep the administra-
tion time <30 min. Although adolescent stakeholders will 
be involved in developing ReACT intervention content 
rated during crowdsourcing, we acknowledge that there 
is a possibility that a higher than expected amount of 
content will be viewed unfavourably during this phase. We 
will review crowdsourcing feedback data from an initial 
wave of 20 participants. In the event that >60% of content 
is viewed unfavourably, we will pause crowdsourcing to 
develop new intervention content.
An advisory board comprising adolescent-caregiver 
dyads and study staff members will convene three times. 
The first meeting will focus on reviewing summative data 
and themes that emerged from crowdsourcing phase. 
The second advisory board meeting will involve discus-
sion about methods to further refine intervention content 
that received 40%–59% ‘no’ votes during crowdsourcing. 
We will incorporate modified content that reaches group 
consensus into applicable ReACT intervention content 
libraries. Preliminary usability testing will take place 
during the final advisory board meeting. Members will 
conduct hands-on testing of ReACT alongside study staff. 
We will use a ‘think aloud’ approach with members as 
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they explore components of the ReACT interface (eg, 
layout, visual feedback), answer EMA questions and view 
intervention content.51 This process more closely approx-
imates actual use and will enable us to receive feedback 
in real-time. The study team will transcribe participants’ 
commentary during testing for review. Results of the 
‘think aloud’ testing will help to inform final design deci-
sions in ReACT.51 For instance, whether content is deliv-
ered using SMS, in-app, push notification or some other 
medium will be informed by user preferences. Advisory 
board participants and their caregivers will also complete 
asthma-related measures to pilot data collection proce-
dures and provide baseline descriptive statistics (table 1). 
Adolescent-caregiver dyads will receive US$50 for each 
advisory board meeting they attend.
Acceptability and usability testing of reACt
In the final phase, adolescents will conduct user testing 
with the alpha version of ReACT. The overarching 
goal is to gather acceptability and usability data from 
the perspectives of target users of ReACT. A sample of 
20 participants will complete a 4-week run-in period to 
Table 1 ReACT outcome measures
Outcome Measure Assessment schedule
Demographics A caregiver-report questionnaire assesses adolescent and family demographic 
characteristics.
II, AB, UT
Asthma morbidity A caregiver-report questionnaire assesses frequency of asthma symptoms, 
exacerbations, activity limitations, missed school days due to asthma, ED visits 
and hospitalisations.
II, AB, UT
Medical information Medical chart review assesses prescribed ICS regimen and dosage. II, AB, UT
Asthma knowledge 
and skills
The Asthma Child Knowledge and Skills Questionnaire,12 a modified version 
of the Children’s Asthma Knowledge Questionnaire,59 is a 30-item adolescent-
report measure that assesses both asthma knowledge and self-assessment of 
skills required for taking medication.
II, AB, UT
Asthma control The Asthma Control Test60 is a 5-item, validated, adolescent-report 




The Asthma Management Efficacy Questionnaire61 is a 14-item, validated, 
adolescent-report questionnaire that assesses asthma self-management 
behaviours.
II, AB, UT
Asthma adherence The Medication Adherence Report Scale for Asthma62 is a 10-item, validated, 
adolescent-report measure of ICS adherence.
II, AB, UT
Self-regulation The Treatment Self-Regulation Questionnaire-Asthma63 is a 15-item, 
adolescent-report measure that assesses motivation for using controller 
medication.
II, AB, UT
Stress The Adolescent Stress Questionnaire64 Revised is a 58-item, validated, 
adolescent-report questionnaire that assesses stressors in adolescence.
II, AB, UT
Social support The Social Support Questionnaire65 is a 27-item, validated, adolescent-report 
measure of social support.
II, AB, UT
Problem solving The Social Problem Solving Inventory-Revised: Short Form66 is a 25-item, 
validated, adolescent-report measure that assesses problem-solving orientation 




PAQLQ67 is a 23-item, validated, adolescent-report questionnaire that measures 
extent of asthma impairment in quality of life.
II, AB, UT
Acceptability The ReAct Satisfaction Questionnaire is an 8-item modification of the Client 
Satisfaction Questionnaire56 that assesses overall participant satisfaction with 
the ReACT intervention. Semi-structured interviews assess what adolescents 
like and do not like about ReACT, its relevance and its perceived helpfulness 
with medication adherence.
UT
Usability The Health Information Technology Usability Evaluation Scale57 is a 20-item, 
validated questionnaire that assesses perceived usefulness, impact on disease, 
perceived ease of use and user control. Think aloud testing gathers stream of 
consciousness data regarding thoughts and feelings of users as they complete 
specified tasks. Semi-structured interviews assess the look and feel of ReACT, 
ease of navigation and experience accessing intervention content.
UT
AB, advisory boards; ED, emergency department; ICS, inhaled corticosteroids; II, design phase I individual interviews; PAQLQ, Pediatric 
Asthma Quality of Life Questionnaire; ReACT, Responsive Asthma Care for Teens; UT, user testing.
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monitor their adherence with all ReACT features turned 
off. Subsequently, study staff will meet with participants to 
complete ReACT orientation. This visit will ensure that 
participants are able to download and use ReACT, and 
that relevant ReACT components (eg, asthma education 
and skills training videos) are accessed before beginning. 
Participants will complete asthma-related study question-
naires (table 1) and then begin a 4-week intervention 
period with all ReACT features activated. Notably, accept-
ability and usability measures will be administered at a 
final study visit at the conclusion of the 4-week interven-
tion period. Again, participants’ comments and sugges-




Study staff will enter transcribed files and expanded notes 
into NVivo. We will code and aggregate interviews using 
a theoretical thematic analysis approach to developing 
themes.52–54 Our theoretical thematic analysis approach 
will use an a priori theoretical framework guided by 
self-regulation theory, informed by advisory board meet-
ings. The investigators will mark comments identified to 
represent discrete thoughts or themes using a semantic 
analysis, and they will use an essential realist approach to 
arrive at themes.52 These patterns or themes will comprise 
the initial set of categories. Research staff will then recode 
the data using these categories and organise major themes 
into summary tables to inform initial development of a 
digital content library. Interviews will continue until no 
new themes emerge in the data coding process (ie, satu-
ration).55 After the coding process is complete, data will 
be described descriptively.
ReACT acceptability
Acceptability of ReACT will be determined in two ways 
during the usability testing phase. First, the ReACT Satis-
faction Questionnaire56 will assess overall satisfaction, 
perceptions regarding how helpful ReACT could be in 
managing asthma and whether adolescents would recom-
mend ReACT to friends with asthma on a 4-point Likert 
scale. An average rating of 3 (mostly satisfied) will be 
considered a successful outcome. Second, the semi-struc-
tured interviews will solicit adolescent feedback about 
ReACT. Our comprehensive interview guide will cover 
a range of topics, including: (1) perceived usefulness of 
ReACT; (2) how effective ReACT might be in changing 
asthma self-management behaviours and (3) suggestions 
on further refining ReACT (eg, incorporating other indi-
viduals). Qualitative data analysis will help determine 
overall project success. The process for identifying themes 
will be similar to the process from the earlier interview 
phase, but in this case we will use an entirely de novo 
process of identifying themes.52 We will mark comments 
identified to represent discrete thoughts or themes using 
a semantic analysis, and we will use an essential realist 
approach to arrive at themes.52 In particular, we will be 
attentive to themes that relate to the acceptability, useful-
ness and user experience of ReACT. Themes that indicate 
that ReACT was perceived to be effective, appropriately 
tailored and acceptable burden will be the criteria for 
success.
ReACT usability
Usability will be determined in three ways. First, an 
average rating of 3 (agree) on the Health Information 
Technology Usability Evaluation Scale57 will be a criterion 
for success. Second, themes from think aloud testing that 
suggest adolescents can navigate the ReACT interface 
intuitively and with minimal difficulty will be markers of 
success. Finally, our semi-structured interview will ask for 
feedback regarding: (1) the layout of the ReACT inter-
face; (2) the navigation experience; (3) clarity of the 
wording; (4) clarity of the video content and (5) ways to 
improve the usability and content of ReACT. These data 
will be used to inform future refinements of ReACT in 
advance of a subsequent trial.
Ethics and dissemination
All research team members will complete certification 
in topics related to the responsible conduct of research. 
To minimise risk from research participation, potential 
subjects will be fully informed regarding the purpose, 
process and amount of time required for participation. 
It is possible that research staff will identify an adolescent 
whose asthma appears undertreated. Research staff will 
review all cases with local medical personnel and facilitate 
a referral for evaluation and appropriate medication if 
indicated.
We plan to disseminate findings from the current 
project to multiple audiences including the local medical 
community and the broader scientific community via 
local and national presentations at relevant conferences 
and meetings. Beyond paediatric asthma, we also envision 
that the ReACT infrastructure and design process can be 
used to develop and test behaviour change interventions 
in other disease populations. If successful, this would be 
a significant step towards the 2016 National Institutes of 
Health-Wide Strategic Plain goal of using mHealth to 
‘enhance health promotion and disease prevention’.58
limitations
The current project is a pilot feasibility, acceptability and 
usability study in a targeted sample (ie, adolescents with 
chronic and persistent asthma), who also have a high need 
for this type of intervention. As such, we will not be able 
to contribute knowledge about the feasibility of ReACT 
in all of the populations it might benefit (eg, adults with 
chronic obstructive pulmonary disease). Moreover, the 
current project is not powered to understand heteroge-
neity of outcomes across sex, socioeconomic status, race, 
culture and literacy levels. The protocol will not incor-
porate shared decision-making between patients and 
providers in the intervention given the focus of ReACT. 
ReACT does not target all of the factors that might 
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influence adherence. Specifically, structural issues such 
as inadequate insurance coverage will not be addressed 
in the current protocol. At this stage, ReACT does not 
involve providers at least in part because there are already 
other commercial systems that do a good job of achieving 
that function. The novelty of ReACT is to identify the 
developmentally appropriate individual-level interven-
tions that can increase adherence.
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